XT
NRXP icon

XTX Topco’s NRX Pharmaceuticals NRXP Stock Holding History

XTX Topco’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$168K Buy
+78,733
New +$159K ﹤0.01% 2909
2024
Q2 		– Sell
-3,940
Closed -$18.6K – 2288
2024
Q1 		$18.6K Buy
+3,940
New +$18.2K ﹤0.01% 1618
2023
Q4 		– Sell
-1,181
Closed -$3.07K – 1945
2023
Q3 		$3.07K Buy
+1,181
New +$3.93K ﹤0.01% 1482

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

XTX Topco's NRXP Position: Q1 2026 in Review

XTX Topco opened a new position in NRX Pharmaceuticals (NRXP) in Q1 2026: 78,733 shares worth $168K. The stake represents ﹤0.01% of the portfolio and ranks #2909 among its holdings. This is a return to the name: XTX Topco previously reported a position in NRXP as recently as Q1 2024.

XTX Topco first reported a position in NRXP in Q3 2023 and has held it in 3 quarters since. 33 funds tracked by Wall St. Rank hold NRXP as of Q1 2026.

  • XTX Topco held 78,733 shares of NRX Pharmaceuticals worth $168K as of Q1 2026.
  • NRX Pharmaceuticals was a new XTX Topco position in Q1 2026.
  • NRX Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2909 holding.
  • XTX Topco first reported a position in NRX Pharmaceuticals in Q3 2023 and has held it in 3 quarters since.
  • 33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.